Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Ibuprofen
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ibuleve Sports 5% gel
1003020P0BCABAC
|
Ibuleve | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibumousse 5%
1003020P0BKAAAF
|
Ibumousse | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 10mg/2ml solution for infusion ampoules
0701011F0AAAAAA
|
Ibuprofen (Neonatal) | Ibuprofen | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Ibuprofen 200mg / Phenylephrine 6.1mg tablets
1001010J0AABSBS
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 200mg effervescent tablets
1001010J0AABPBP
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 300mg modified-release / Codeine 20mg tablets
1001010J0AAARAR
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 5% cream
1003020P0AAAAAA
|
Ibuprofen (Topical Antirheumatic) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 5% foam
1003020P0AAAFAF
|
Ibuprofen (Topical Antirheumatic) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibuprofen 800mg tablets
1001010J0AAAGAG
|
Ibuprofen (NSAID) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ibutop Ralgex Ibuprofen 5% gel
1003020P0BIAAAC
|
Ralgex (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Junior Ibuprofen 100mg/5ml oral suspension
1001010J0CDABBH
|
Numark Ibuprofen (Systemic) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Librofem 200mg tablets
1001010J0BSAAAD
|
Librofem | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Lloydspharmacy Ibuprofen 100mg/5ml oral suspension
1001010J0CMAFBH
|
Lloydspharmacy (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Lloydspharmacy Ibuprofen 200mg liquid capsules
1001010J0CMADAA
|
Lloydspharmacy (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Lloydspharmacy Ibuprofen Long Lasting 200mg capsules
1001010J0CMACBA
|
Lloydspharmacy (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Lloydspharmacy Maximum Strength Ibuprofen 10% gel
1003020P0BRAAAI
|
Lloydspharmacy (Topical Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Lloydspharmacy Maximum Strength Ibuprofen 400mg liq caps
1001010J0CMAEAU
|
Lloydspharmacy (Ibuprofen) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Mandafen 400mg tablets
1001010J0CYABAE
|
Mandafen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Mandafen 600mg tablets
1001010J0CYACAF
|
Mandafen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Mandafen for Children 100mg/5ml oral suspension sugar free
1001010J0CYAABH
|
Mandafen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Manorfen 200mg tablets
1001010J0CTABAD
|
Manorfen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Manorfen 400mg tablets
1001010J0CTAAAE
|
Manorfen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Migrafen 200mg tablets
1001010J0B2AAAD
|
Migrafen | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Motrin 400mg tablets
1001010J0BHABAE
|
Motrin | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Motrin 600mg tablets
1001010J0BHACAF
|
Motrin | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.